A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies

Summary

This is a Phase 2 study to assess the efficacy of SB1518 in the treatment of patients with advanced lymphoid malignancies including Hodgkin Lymphoma, Mantle Cell Lymphoma and Indolent Lymphoma (follicular lymphoma, lymphoplasmacytic lymphoma, marginal zone lymphoma and small lymphocytic lymphoma).

Timeline

Start

2010-12

Primary completion

2012-02

Completion

2012-02

Drugs

Indications